rn3161
Nucleic acidexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 4, 2025 (NCT07245771)
Timeline
2020s
- Jan 1, 2025
Earliest Phase 1 Sponsor(trial)
Mechanism of action
- Inhibin beta E chainANTISENSE INHIBITOR
INHBE antisense inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07245771 | Phase 1/Phase 2 (Phase 2) | Nov 4, 2025 | Government of China, Ikaria, Nucleus Network Ltd |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of China | Government | 1 | 0 | 1 | 2025 |
| Ikaria | For profit | 1 | 1 | 1 | 2025 |
| Nucleus Network Ltd | For profit | 1 | 0 | 1 | 2025 |
3 organizations
Page 1 / 1